NasdaqGM - Delayed Quote
USD
Braveheart Bio, Inc. (BRVE)
18.60
+1.19
(+6.80%)
At close: November 6 at 4:00:01 PM EST
Loading chart for BRVE
- Previous Close
17.42 - Open
17.55 - Bid --
- Ask --
- Day's Range
16.89 - 18.99 - 52 Week Range
16.70 - 32.00 - Volume
702,051 - Avg. Volume
452,921 - Market Cap (intraday)
1.675B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-6.08 - Earnings Date (est.) Nov 12, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
45.25 - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
BRVE
38.41%
S&P 500 (^GSPC)
7.76%
1-Year Return
BRVE
38.41%
S&P 500 (^GSPC)
9.77%
3-Year Return
BRVE
38.41%
S&P 500 (^GSPC)
68.96%
5-Year Return
BRVE
38.41%
S&P 500 (^GSPC)
57.04%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
--
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-98.45M
-
Diluted EPS (ttm)
-6.08
Balance Sheet and Cash Flow
-
Total Cash (mrq)
122.83M
-
Total Debt/Equity (mrq)
0.49%
-
Levered Free Cash Flow (ttm)
--
